CAT and metabolic dysfunction-associated steatotic liver disease: The neutral polysaccharide (CPP-1) could protect cells from oxidative damage (increasing the activity of SOD and CAT and reducing the MDA content), reduce the body fat index of nonalcoholic fatty liver disease mice, and improve the liver function (34).